search
Back to results

Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy (LPD)

Primary Purpose

Type 1 Diabetes Mellitus With Diabetic Nephropathy

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
low protein diet
normal protein diet
Sponsored by
Steno Diabetes Center Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 1 Diabetes Mellitus With Diabetic Nephropathy focused on measuring survival, protein restriction, diabetic nephropathy, type 1 diabetes, GFR, ESRD, progressive renal disease

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diabetes mellitus type 1
  • duration at least 10 years
  • onset before age of 35,
  • presence of diabetic retinopathy
  • albuminuria>=300mg/24 h in at least 2/3 sterile urine samples
  • no clinical or laboratory evidence of other kidney or urinary tract disease
  • GFR above 20mL/min/1.73M2
  • pre-study decline in GFR>= 2 mL/min/year

Exclusion Criteria:

  • pregnancy
  • history of congestive heart failure or myocardial infarction or coronary bypass surgery within the last three months

Sites / Locations

  • Steno Diabetes Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Low protein diet

Normal protein diet

Arm Description

Outcomes

Primary Outcome Measures

Cumulative incidence of ESRD requiring dialysis or transplantation, and death
Cause of death was obtained from death certificate by an independent observer. Before the development of uremic symptoms, patients were referred to the department of nephrology at the University Hospital of Herlev or Rigshospitalet, when GFR deteriorated below 10 to 20 ML/min/1.73m2, where accepted criteria for initiation of dialysis and transplantation were applied on patients from both diet groups. Patients continued their scheduled visits and treatment in the study until the end of the four-year follow up. This was assesed every 3 months until the end of the 4 year follow up period.
Rate of decline of GFR
rate of decline was measured if the patient had a minimum of one year of follow up and a minimum of 3 GFR measures during the study. All measures of GFR during the study period (including baseline) were used to calculate the rate of decline(the slopes) of GFR. GFR was measured every 6 months during the 4 years of follow up.

Secondary Outcome Measures

Full Information

First Posted
January 13, 2012
Last Updated
January 30, 2012
Sponsor
Steno Diabetes Center Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT01521910
Brief Title
Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy
Acronym
LPD
Official Title
Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2012
Overall Recruitment Status
Completed
Study Start Date
April 1995 (undefined)
Primary Completion Date
June 2000 (Actual)
Study Completion Date
June 2000 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Steno Diabetes Center Copenhagen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the investigators study was to determine the effect of dietary protein restriction on survival and progression to end stage renal disease (ESRD) in diabetic nephropathy.
Detailed Description
The study was a prospective, randomized, unmasked, controlled trial carried out at the Steno Diabetes Center. With concealed randomization the patients were (in blocks of two according to the level of GFR) assigned to receive either a usual-protein diet or a low-protein diet. After randomization an iso-caloric low-protein diet of 0.6 g/kg/day was prescribed to patients in the low-protein diet group. The usual-pro tein diet consisted of the patients' pre-study diet. The planned duration of follow-up was four years, scheduled visits every three-months. All patients gave complete history of medication, underwent examination of weight, urinary albumin-, sodium- and urea excretion, serum albumin, serum urea, hemoglobin, hemoglobin A1c, blood pressure, serum total-cholesterol, high-density lipoprotein (HDL) cholesterol. GFR, serum triglycerides,calcium and phosphorous, anthropometric measurements, nutritional status and smoking habits were evaluated every six months. Dietary protein intake was estimated on the basis of three consecutive 24-hour urine samples completed before each visit, using urinary excretion of urea nitrogen. GFR was measured by plasma clearance of 51Cr-EDTA over a 4 hour period and standardized for 1.73m2 body surface area using the same surface for each patient during the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes Mellitus With Diabetic Nephropathy
Keywords
survival, protein restriction, diabetic nephropathy, type 1 diabetes, GFR, ESRD, progressive renal disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
82 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low protein diet
Arm Type
Experimental
Arm Title
Normal protein diet
Arm Type
Active Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
low protein diet
Intervention Description
An iso-caloric low protein diet of 0.6 g/kg/day was prescribed during the whole study duration. The same dietician gave nutritional advices at least every three months during the whole study period. Patients were also seen by the same doctor during each visit for the whole study period. Supplementation of Calcium of 500mg/day. Urine albumin losses >= 2 g/day wre replaced by increasing dietary protein on a gram-for-gram basis, only if the patient was compliant with the prescribed low-protein diet.
Intervention Type
Dietary Supplement
Intervention Name(s)
normal protein diet
Intervention Description
The patients pre-study diet during the whole study period Patients were also seen by the same doctor during each visit for the whole study period.
Primary Outcome Measure Information:
Title
Cumulative incidence of ESRD requiring dialysis or transplantation, and death
Description
Cause of death was obtained from death certificate by an independent observer. Before the development of uremic symptoms, patients were referred to the department of nephrology at the University Hospital of Herlev or Rigshospitalet, when GFR deteriorated below 10 to 20 ML/min/1.73m2, where accepted criteria for initiation of dialysis and transplantation were applied on patients from both diet groups. Patients continued their scheduled visits and treatment in the study until the end of the four-year follow up. This was assesed every 3 months until the end of the 4 year follow up period.
Time Frame
4 years
Title
Rate of decline of GFR
Description
rate of decline was measured if the patient had a minimum of one year of follow up and a minimum of 3 GFR measures during the study. All measures of GFR during the study period (including baseline) were used to calculate the rate of decline(the slopes) of GFR. GFR was measured every 6 months during the 4 years of follow up.
Time Frame
4 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diabetes mellitus type 1 duration at least 10 years onset before age of 35, presence of diabetic retinopathy albuminuria>=300mg/24 h in at least 2/3 sterile urine samples no clinical or laboratory evidence of other kidney or urinary tract disease GFR above 20mL/min/1.73M2 pre-study decline in GFR>= 2 mL/min/year Exclusion Criteria: pregnancy history of congestive heart failure or myocardial infarction or coronary bypass surgery within the last three months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Henrik P Hansen, MD
Organizational Affiliation
Steno Diabetes Center Copenhagen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Steno Diabetes Center
City
Gentofte
ZIP/Postal Code
2820
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy

We'll reach out to this number within 24 hrs